The SCCS Polypill Pilot Trial

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 303 participants.

Also called NCT02278471

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 303 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02278471
Other papers using this trial's data
  • Polypill for Cardiovascular Disease Prevention in an Underserved Population The New England journal of medicine, 2019-09-19 DOI, PubMed 31532959, PMC6938029 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02278471. Randomized; no masking; primary purpose prevention. Start 2015-12 (actual); primary completion 2018-06-27 (actual). Results posted on 2019-10-01.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The SCCS Polypill Pilot Trial
Condition
Hypertension
Condition
Hyperlipidemia
Intervention (Drug)
Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide)
Lead sponsor
Vanderbilt University (class: other)

Record details

Record id
cardio:ct-nct02278471
Content hash
9160c89a8d4cd5b1f79745ce554c1de5abf2ee39068d45c1e9eb6c2f1310c4a7